Literature DB >> 34854066

Nonalcoholic fatty liver disease: lifestyle and quality of life.

Ilias Vachliotis1,2, Antonis Goulas3, Paraskevi Papaioannidou3, Stergios A Polyzos3.   

Abstract

Nonalcoholic fatty liver disease (NAFLD) is a metabolic disorder whose current rapidly expanding prevalence is causing it to develop into a major global health concern. NAFLD is closely linked to the modern, unhealthy lifestyle. The Western diet, characterized by excessive energy intake, frequent consumption of red meat, processed meat and foods, soft drinks, and sugar-sweetened beverages (SSBs), irregular meal distribution throughout the day, and unhealthy ways of cooking, predisposes to development of NAFLD. Low levels of physical activity and prolonged sedentary time are additional lifestyle risk factors for NAFLD. Given the present lack of effective pharmacological treatment, lifestyle modifications are regarded as the cornerstone of NAFLD management. Reducing daily calorie intake together with following the Mediterranean diet (MD) is an increasingly accepted approach. Furthermore, increasing the level of physical activity and limiting sedentary behavior are additional measures proposed to improve the outcomes of the disease. Apart from being affected by lifestyle, NAFLD may also affect patients' quality of life (QoL), mostly in the domain of physical function. In this regard, while the early and more benign form of the disease, i.e., simple hepatic steatosis, may not affect QoL, there is evidence, though conflicting, of the impact of nonalcoholic steatohepatitis (NASH) on this index, with, however, most studies showing that QoL is consistently affected in advanced disease, i.e., hepatic fibrosis, cirrhosis, and hepatocellular carcinoma. Considering all the above, appropriate management of lifestyle is likely to attenuate the severity of the disease and improve the QoL of NAFLD patients.
© 2021. Hellenic Endocrine Society.

Entities:  

Keywords:  Diet; Lifestyle; Nonalcoholic fatty liver disease; Nonalcoholic steatohepatitis; Physical activity; Quality of life

Mesh:

Year:  2021        PMID: 34854066     DOI: 10.1007/s42000-021-00339-6

Source DB:  PubMed          Journal:  Hormones (Athens)        ISSN: 1109-3099            Impact factor:   2.885


  42 in total

Review 1.  Nonalcoholic fatty liver disease: multimodal treatment options for a pathogenetically multiple-hit disease.

Authors:  Stergios A Polyzos; Jannis Kountouras; Christos Zavos; Georgia Deretzi
Journal:  J Clin Gastroenterol       Date:  2012-04       Impact factor: 3.062

2.  Relationship between dietary patterns and non-alcoholic fatty liver disease: A systematic review and meta-analysis.

Authors:  Shirin Hassani Zadeh; Anahita Mansoori; Mahdieh Hosseinzadeh
Journal:  J Gastroenterol Hepatol       Date:  2020-12-14       Impact factor: 4.029

Review 3.  Obesity and nonalcoholic fatty liver disease: From pathophysiology to therapeutics.

Authors:  Stergios A Polyzos; Jannis Kountouras; Christos S Mantzoros
Journal:  Metabolism       Date:  2018-11-29       Impact factor: 8.694

4.  Diet Associations With Nonalcoholic Fatty Liver Disease in an Ethnically Diverse Population: The Multiethnic Cohort.

Authors:  Mazen Noureddin; Shira Zelber-Sagi; Lynne R Wilkens; Jacqueline Porcel; Carol J Boushey; Loïc Le Marchand; Hugo R Rosen; Veronica Wendy Setiawan
Journal:  Hepatology       Date:  2020-02-14       Impact factor: 17.425

Review 5.  Epidemiology, Pathogenesis, Diagnosis and Emerging Treatment of Nonalcoholic Fatty Liver Disease.

Authors:  Evangelia Makri; Antonis Goulas; Stergios A Polyzos
Journal:  Arch Med Res       Date:  2020-12-14       Impact factor: 2.235

Review 6.  Nonalcoholic fatty liver disease: the pathogenetic roles of insulin resistance and adipocytokines.

Authors:  Stergios A Polyzos; Jannis Kountouras; Christos Zavos
Journal:  Curr Mol Med       Date:  2009-04       Impact factor: 2.222

Review 7.  Association of sugar sweetened beverages consumption with non-alcoholic fatty liver disease: a systematic review and meta-analysis.

Authors:  Farzaneh Asgari-Taee; Nahid Zerafati-Shoae; Mohsen Dehghani; Masoumeh Sadeghi; Hamid R Baradaran; Shima Jazayeri
Journal:  Eur J Nutr       Date:  2018-05-14       Impact factor: 5.614

Review 8.  The Impact of Macronutrient Intake on Non-alcoholic Fatty Liver Disease (NAFLD): Too Much Fat, Too Much Carbohydrate, or Just Too Many Calories?

Authors:  Theresa Hydes; Uazman Alam; Daniel J Cuthbertson
Journal:  Front Nutr       Date:  2021-02-16

9.  Fructose, high-fructose corn syrup, sucrose, and nonalcoholic fatty liver disease or indexes of liver health: a systematic review and meta-analysis.

Authors:  Mei Chung; Jiantao Ma; Kamal Patel; Samantha Berger; Joseph Lau; Alice H Lichtenstein
Journal:  Am J Clin Nutr       Date:  2014-08-06       Impact factor: 7.045

10.  Nonalcoholic fatty liver disease is associated with excessive calorie intake rather than a distinctive dietary pattern.

Authors:  Malte H Wehmeyer; Birgit-Christiane Zyriax; Bettina Jagemann; Ewgenia Roth; Eberhard Windler; Julian Schulze Zur Wiesch; Ansgar W Lohse; Johannes Kluwe
Journal:  Medicine (Baltimore)       Date:  2016-06       Impact factor: 1.889

View more
  3 in total

Review 1.  Targeted therapeutics and novel signaling pathways in non-alcohol-associated fatty liver/steatohepatitis (NAFL/NASH).

Authors:  Xiaohan Xu; Kyle L Poulsen; Lijuan Wu; Shan Liu; Tatsunori Miyata; Qiaoling Song; Qingda Wei; Chenyang Zhao; Chunhua Lin; Jinbo Yang
Journal:  Signal Transduct Target Ther       Date:  2022-08-13

Review 2.  Combination Therapies for Nonalcoholic Fatty Liver Disease.

Authors:  Evangelia S Makri; Eleftheria Makri; Stergios A Polyzos
Journal:  J Pers Med       Date:  2022-07-18

3.  Association of changes in histologic severity of nonalcoholic steatohepatitis and changes in patient-reported quality of life.

Authors:  Laura Heath; Paul Aveyard; Jeremy W Tomlinson; Jeremy F Cobbold; Dimitrios A Koutoukidis
Journal:  Hepatol Commun       Date:  2022-07-28
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.